QR Code

High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort study

Background: Rifampicin-resistant tuberculosis (RR-TB) remains a global health challenge, which is often characterized by limited treatment options and increased morbidity and mortality. Despite advances in diagnostics and the introduction of new drug regimens, treatment success for drug-resistant TB...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Tuelo Mogashoa, Justice T. Ngom, Ontlametse T. Choga, Johannes Loubser, Phenyo Sabone, Tuduetso Molefi, Topo Makhondo, One Stephen, Joseph M. Makhema, Rosemary M. Musonda, Keabetswe Fane, Simani Gaseitsiwe, Rob M. Warren, Sikhulile Moyo, Anzaan Dippenaar, Elizabeth M. Streicher
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2026-04-01
Rangatū:Journal of Infection and Public Health
Ngā marau:
Botswana
drug-resistant TB
rifampicin-resistant tuberculosis
treatment outcomes
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S1876034126000419
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite